Sommaire

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Authors

    Page :A6

    
• • ·Information for Readers

    Page :A8

    

• Editorial

  • ·Omega-3 fatty acids and ventricular arrhythmias: Nothing is simple

    Page :967-970

    Christine M. Albert

    

• Clinical Investigations

  • ·Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure

    Page :971-977

    Matthias Wilhelm, Rueth Tobias, Fatima Asskali, Robert Kraehner, Simone Kuly, Lutz Klinghammer, Hansjosef Boehles, Werner Guenther Daniel

    Résumé Résumé Plan Plan  
  • ·Resource utilization in patients hospitalized with heart failure: Insights from a contemporary national hospital database

    Page :978

    Paul J. Hauptman, Jason Swindle, Thomas E. Burroughs, Mark A. Schnitzler

    Résumé Résumé Plan Plan  
  • ·Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure

    Page :986-991

    Maxime Cournot, Fabien Mourre, Fabienne Castel, Jean Ferrières, Sylvain Destrac

    Résumé Résumé Plan Plan  
  • ·Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure

    Page :992-997

    Esther E. Vorovich, Shaokun Chuai, Mingyao Li, Justin Averna, Victor Marwin, David Wolfe, Muredach P. Reilly, Thomas P. Cappola

    Résumé Résumé Plan Plan  
  • ·Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from the Pediatric Cardiomyopathy Registry

    Page :998-1005

    David M. Connuck, Lynn A. Sleeper, Steven D. Colan, Gerald F. Cox, Jeffrey A. Towbin, April M. Lowe, James D. Wilkinson, E. John Orav, Leigha Cuniberti, Bonnie A. Salbert, Steven E. Lipshultz, for the Pediatric Cardiomyopathy Registry Study Group

    Résumé Résumé Plan Plan  
  • ·High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly

    Page :1006-1012

    Robert C. Kaplan, Aileen P. McGinn, Michael N. Pollak, Lewis Kuller, Howard D. Strickler, Thomas E. Rohan, Anne R. Cappola, XiaoNan Xue, Bruce M. Psaty

    Résumé Résumé Plan Plan  
  • ·Renal effects of ularitide in patients with decompensated heart failure

    Page :1012.e1

    Hartmut Lüss, Veselin Mitrovic, Petar M. Seferovic, Dejan Simeunovic, Arsen D. Risti?, Valentin S. Moiseyev, Wolf-Georg Forssmann, Ahmed M. Hamdy, Markus Meyer

    Résumé Résumé Plan Plan  
  • ·Loss of diastolic time as a mechanism of exercise-induced diastolic dysfunction in dilated cardiomyopathy

    Page :1013-1019

    Gunnar Plehn, Julia Vormbrock, Christian Perings, Sebastian Machnick, Christian Zuehlke, Hans-Joachim Trappe, Axel Meissner

    Résumé Résumé Plan Plan  
  • ·Subclinical atherosclerosis in subjects with family history of premature coronary artery disease

    Page :1020

    Catalin Taraboanta, Evelyn Wu, Scott Lear, Stefanie DiPalma, John Hill, G.B. John Mancini, Jiri Frohlich

    Résumé Résumé Plan Plan  
  • ·Impact of race and chronic kidney disease on 1-year outcome in patients undergoing percutaneous coronary interventions: A single tertiary center experience

    Page :1027-1032

    Francesca Cardarelli, Antonio Bellasi, Emir Veledar, Viola Vaccarino, Paolo Raggi

    Résumé Résumé Plan Plan
  • ·Age-adjusted modification of the Duke Treadmill Score nomogram

    Page :1033-1038

    Amir H. Sadrzadeh Rafie, Frederick E. Dewey, Jonathan Myers, Victor F. Froelicher

    Résumé Résumé Plan Plan  
  • ·Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival : Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial

    Page :1039-1046

    Marc A. Brouwer, Peter C. Kievit, Hendrik-Jan Dieker, Gerrit Veen, Aart J. Karreman, Freek W.A. Verheugt

    Résumé Résumé Plan Plan  
  • ·Transfusion practice and outcomes in non–ST-segment elevation acute coronary syndromes

    Page :1047-1053

    Karen P. Alexander, Anita Y. Chen, Tracy Y. Wang, Sunil V. Rao, L. Kristin Newby, Nancy M. Allen LaPointe, E. Magnus Ohman, Matthew T. Roe, William E. Boden, Robert A. Harrington, Eric D. Peterson, for the CRUSADE Investigators

    Résumé Résumé Plan Plan  
  • ·Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door-to-balloon times in primary percutaneous coronary intervention

    Page :1054-1058

    Michael F. Dorsch, John P. Greenwood, Claire Priestley, Kathryn Somers, Carole Hague, Jonathan M. Blaxill, Stephen B. Wheatcroft, Alan F. Mackintosh, James M. McLenachan, Daniel J. Blackman

    Résumé Résumé Plan Plan  
  • ·Achieving rapid reperfusion with primary percutaneous coronary intervention remains a challenge: Insights from American Heart Association's Get With the Guidelines program

    Page :1059-1067

    Rajendra H. Mehta, Vincent J. Bufalino, Wenqin Pan, Adrian F. Hernandez, Christopher P. Cannon, Gregg C. Fonarow, Eric D. Peterson, on behalf of the American Heart Association Get With the Guidelines Investigators

    Résumé Résumé Plan Plan  
  • ·Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score

    Page :1068-1074

    Pankaj Madan, MacArthur A. Elayda, Vei-Vei Lee, James M. Wilson

    Résumé Résumé Plan Plan  
  • ·Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents

    Page :1075-1080

    Mehdi H. Shishehbor, Reza Amini, Russell E. Raymond, Anthony A. Bavry, Sorin J. Brener, Samir R. Kapadia, Patrick L. Whitlow, Stephen G. Ellis, Deepak L. Bhatt

    Résumé Résumé Plan Plan
  • ·Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention

    Page :1081-1089

    Giuseppe G.L. Biondi-Zoccai, Marzia Lotrionte, Matteo Anselmino, Claudio Moretti, Pierfrancesco Agostoni, Luca Testa, Antonio Abbate, John Cosgrave, Antonio Laudito, Gian Paolo Trevi, Imad Sheiban

    Résumé Résumé Plan Plan  
  • ·Contemporary outcomes of rescue percutaneous coronary intervention for acute myocardial infarction: Comparison with primary angioplasty and the role of distal protection devices (EMERALD trial)

    Page :1090-1096

    George Dangas, Gregg W. Stone, Mitchell D. Weinberg, John Webb, David A. Cox, Bruce R. Brodie, Mitchell W. Krucoff, Raymond J. Gibbons, Alexandra J. Lansky, Roxana Mehran, for the EMERALD Investigators

    Résumé Résumé Plan Plan  
  • ·The costs of drug-eluting coronary stents among Medicare beneficiaries

    Page :1097-1105

    Peter W. Groeneveld, Mary Anne Matta, Alexis P. Greenhut, Feifei Yang

    Résumé Résumé Plan Plan  
  • ·Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-Month results of a randomized clinical trial

    Page :1106-1113

    Ann-Dorthe Olsen Zwisler, Anne Merete Boas Soja, Søren Rasmussen, Marianne Frederiksen, Sadollah Abadini, Jon Appel, Hanne Rasmussen, Christian Gluud, Lars Iversen, Bjarne Sigurd, Mette Madsen, Jørgen Fischer-Hansen, for the DANREHAB Group e

    Résumé Résumé Plan Plan  
  • ·Prognostic value of preoperative indexed end-systolic left ventricle diameter in the outcome after surgery in patients with chronic aortic regurgitation

    Page :1114-1120

    Antonia Sambola, Pilar Tornos, Ignacio Ferreira-Gonzalez, Artur Evangelista

    Résumé Résumé Plan Plan  
  • ·Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy

    Page :1121-1127

    Frank Lloyd Dini, Paolo Fontanive, Umberto Conti, Diana Andreini, Enrico Cabani, Salvatore Mario De Tommasi

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :1127

    
  • ·Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy

    Page :1128-1134

    J. Martijn Bos, Jeanne L. Theis, A. Jamil Tajik, Bernard J. Gersh, Steve R. Ommen, Michael J. Ackerman

    Résumé Résumé Plan Plan  
  • ·Impact of valve prosthesis-patient mismatch estimated by echocardiographic-determined effective orifice area on long-term outcome after aortic valve replacement

    Page :1135-1142

    Ines Florath, Alexander Albert, Ulrich Rosendahl, Ina Carolin Ennker, Jürgen Ennker

    Résumé Résumé Plan Plan  
  • ·Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: A randomized controlled trial

    Page :1143-1149

    A. Selcuk Adabag, Areef Ishani, Suresh Koneswaran, Deborah J. Johnson, Rosemary F. Kelly, Herbert B. Ward, Edward O. McFalls, Hanna E. Bloomfield, Yellaprada Chandrashekhar

    Résumé Résumé Plan Plan  
  • ·Efficacy of culprit plaque assessment by 64-slice multidetector computed tomography to predict transient no-reflow phenomenon during percutaneous coronary intervention

    Page :1150-1157

    Gaku Nakazawa, Kengo Tanabe, Yoshinobu Onuma, Sen Yachi, Jiro Aoki, Hirosada Yamamoto, Yasutomi Higashikuni, Atsuhiko Yagishita, Hiroyoshi Nakajima, Kazuhiro Hara

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Reversible ischemia as an indication for revascularization in stable angina–One more paradigm to challenge

    Page :e45

    Subodh B. Joshi

    
  • ·Dual antithrombotic therapy and hypercoagulability in diabetic patients

    Page :e47

    Marijan Bosevski, Ljubica Georgievska-Ismail, Vladimir Borozanov

    
  • ·Response to the letter regarding the article “Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: The PLavix Use for Treatment of Diabetes (PLUTO-Diabetes) trial”

    Page :e49

    Victor Serebruany

    
  • ·Distribution of creatine kinase in sedentary and physically active individuals

    Page :e51

    Giuseppe Lippi, Giuseppe Banfi

    
  • ·Statins in the prevention of postoperative atrial fibrillation: Is there really no effect?

    Page :e53

    Maciej Banach, Jan Henryk Goch, Murat Ugurlucan, Giovanni Mariscalco, Jacek Rysz

    
  • ·Reply

    Page :e55

    Salim S. Virani, Christie M. Ballantyne

    
  • ·Role of magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy

    Page :e57

    Robin Nijveldt, Tjeerd Germans, Albert C. van Rossum,